The choice between Warfarin and Apixaban has become increasingly relevant in discussions surrounding anticoagulant therapy. As the prevalence of conditions such as atrial fibrillation and venous thromboembolism rises, understanding the nuances of these two medications is essential for both healthcare providers and patients. Anticoagulants play a crucial role in preventing blood clots, which can lead to serious health complications, including stroke and pulmonary embolism. Warfarin, a traditional anticoagulant, has been used for decades and is known for its effectiveness, but it comes with certain dietary restrictions and requires regular monitoring of blood levels. In contrast, Apixaban is a newer medication that falls into the category of direct oral anticoagulants (DOACs).…